Insider · CIK 0001376797

Cleveland Paul B

Reports to the SEC for 5 companies · PALO ALTO, CA

sec.gov

Transactions

Companies

Filings

CIK

0001376797

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2019-10-22	ALDER BIOPHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−22.5K sh	—	—	0
2019-10-22	ALDER BIOPHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−12.7K sh	—	—	0
2019-10-22	ALDER BIOPHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−17.3K sh	—	—	0
2019-10-22	ALDER BIOPHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2019-10-22	ALDER BIOPHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−15K sh	—	—	0
2019-10-22	ALDER BIOPHARMACEUTICALS INCStock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−100K sh	—	—	0
2019-05-23	ALDER BIOPHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+22.5K sh	—	—	22,500
2018-05-31	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+35K sh	—	—	35,000
2018-03-26	ALDER BIOPHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+100K sh	—	—	100,000
2017-06-12	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+33.6K sh	—	—	33,602
2017-06-12	Adverum Biotechnologies, Inc.A Award	Director	AAward	+22.7K sh	—	—	22,727
2017-05-24	ALDER BIOPHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2016-06-14	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2016-05-26	ALDER BIOPHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2016-05-11	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+381K sh	—	—	381,000
2015-12-09	Adverum Biotechnologies, Inc.Stock Option (Right to Buy)A Award	Director	AAward	+910K sh	—	—	910,000
2015-09-30	ALDER BIOPHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+17.3K sh	—	—	17,300
2015-08-26	ALDER BIOPHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+12.7K sh	—	—	12,700
2015-06-22	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2015-01-01	Eiger BioPharmaceuticals, Inc.Stock option (right to buy)A Award	President and CFO	AAward	+140K sh	—	—	417,500
2014-01-15	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−8,333 sh	—	—	1,667
2014-01-15	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	Director	MExercise/Conversion	+8,333 sh	$5.03	+$41.9K	8,333
2014-01-15	SGMOQSANGAMO THERAPEUTICS, INCS Sale	Director	SSale	−8,333 sh	$18.68	−$156K	0
2013-12-02	SGMOQSANGAMO THERAPEUTICS, INCS Sale	Director	SSale	−10K sh	$11.64	−$116K	0
2013-12-02	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2013-12-02	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$6.41	+$64.1K	10,000
2013-10-21	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$4.54	+$45.4K	10,000
2013-10-21	SGMOQSANGAMO THERAPEUTICS, INCS Sale	Director	SSale	−10K sh	$10.93	−$109K	0
2013-10-21	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2013-09-03	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−7,278 sh	—	—	0
2013-09-03	SGMOQSANGAMO THERAPEUTICS, INCS Sale	Director	SSale	−7,278 sh	$10.30	−$75K	0
2013-09-03	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	Director	MExercise/Conversion	+7,278 sh	$2.04	+$14.8K	7,278
2013-07-15	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	Director	MExercise/Conversion	+8,000 sh	$2.04	+$16.3K	8,000
2013-07-15	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	+8,000 sh	—	—	7,278
2013-07-15	SGMOQSANGAMO THERAPEUTICS, INCS Sale	Director	SSale	−8,000 sh	$9.59	−$76.7K	0
2013-06-12	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2012-06-21	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2011-06-01	SGMOQSANGAMO THERAPEUTICS, INC · Stock Option (Right to Buy)A Award	Director	AAward	+10K sh	—	—	10,000
2011-02-28	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	Director	MExercise/Conversion	+1,388 sh	$2.04	+$2,831.52	1,388
2011-02-28	SGMOQSANGAMO THERAPEUTICS, INCS Sale	Director	SSale	−1,388 sh	$9.00	−$12.5K	0
2011-02-28	SGMOQSANGAMO THERAPEUTICS, INC · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−1,388 sh	—	—	15,278
2010-12-22	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	Director	MExercise/Conversion	+10K sh	$4.10	+$41K	32,037
2010-12-22	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	Director	MExercise/Conversion	+22K sh	$2.04	+$45K	22,037
2010-12-22	SGMOQSANGAMO THERAPEUTICS, INC · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−22K sh	—	—	16,666
2010-12-22	SGMOQSANGAMO THERAPEUTICS, INCS Sale	Director	SSale	−10K sh	$7.00	−$70K	0
2010-12-22	SGMOQSANGAMO THERAPEUTICS, INC · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−10K sh	—	—	0
2010-12-22	SGMOQSANGAMO THERAPEUTICS, INCS Sale	Director	SSale	−22K sh	$7.00	−$154K	10,000
2010-12-20	SGMOQSANGAMO THERAPEUTICS, INC · Employee Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−11.3K sh	—	—	38,703
2010-12-20	SGMOQSANGAMO THERAPEUTICS, INCS Sale	Director	SSale	−11.3K sh	$7.00	−$79.1K	0
2010-12-20	SGMOQSANGAMO THERAPEUTICS, INCM Exercise/Conversion	Director	MExercise/Conversion	+11.3K sh	$2.04	+$23K	11,297

Recent filings

Accepted (ET)
Oct 244
Cleveland Paul B0001209191-19-053912
SEC(opens sec.gov)
May 284
Cleveland Paul B0001209191-19-033067
SEC(opens sec.gov)
Jun 154
Cleveland Paul B0001209191-18-038052
SEC(opens sec.gov)
Mar 274
Cleveland Paul B0001209191-18-021826
SEC(opens sec.gov)
Jun 144
Adverum Biotechnologies, Inc.0001209191-17-039965
SEC(opens sec.gov)
May 264
ALDER BIOPHARMACEUTICALS INC0001209191-17-035993
SEC(opens sec.gov)
Jun 154
SANGAMO BIOSCIENCES INC0001140361-16-069928
SEC(opens sec.gov)
Jun 24
ALDER BIOPHARMACEUTICALS INC0001209191-16-125284
SEC(opens sec.gov)
May 134
Adverum Biotechnologies, Inc.0001209191-16-120031
SEC(opens sec.gov)
Dec 114
Avalanche Biotechnologies, Inc.0001209191-15-084729
SEC(opens sec.gov)
Oct 24
ALDER BIOPHARMACEUTICALS INC0001209191-15-073545
SEC(opens sec.gov)
Aug 274
ALDER BIOPHARMACEUTICALS INC0001209191-15-068297
SEC(opens sec.gov)
Jun 244
SANGAMO BIOSCIENCES INC0001140361-15-025331
SEC(opens sec.gov)
Jan 54
Celladon Corp0001209191-15-001712
SEC(opens sec.gov)

Companies

Address

C/O AFFYMAX, INC. 4001 MIRANDA AVE.

PALO ALTO, CA, 94304